SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-003287
Filing Date
2024-01-23
Accepted
2024-01-23 08:48:49
Documents
15
Period of Report
2024-01-23
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K n70019397x1_8k.htm   iXBRL 8-K 50230
2 EXHIBIT 3.1 ny20019397x1_ex3-1.htm EX-3.1 10025
3 EXHIBIT 3.2 ny20019397x1_ex3-2.htm EX-3.2 82174
4 EXHIBIT 99.1 ny20019397x1_ex99-1.htm EX-99.1 152194
  Complete submission text file 0001140361-24-003287.txt   493473

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrtx-20240123.xsd EX-101.SCH 3860
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrtx-20240123_lab.xml EX-101.LAB 23292
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrtx-20240123_pre.xml EX-101.PRE 16549
9 EXTRACTED XBRL INSTANCE DOCUMENT n70019397x1_8k_htm.xml XML 4196
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 24550538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)